Holistic Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
1,251
+513
+70% +$524K 0.23% 98
2026
Q1
$679K Buy
738
+60
+9% +$60.8K 0.14% 145
2025
Q4
$729K Buy
678
+80
+13% +$76.5K 0.16% 124
2025
Q3
$457K Buy
598
+84
+16% +$62.5K 0.12% 137
2025
Q2
$401K Buy
514
+227
+79% +$176K 0.11% 143
2025
Q1
$237K Buy
+287
New +$239K 0.08% 166
2024
Q4
Sell
-249
Closed -$221K 177
2024
Q3
$221K Sell
249
-19
-7% -$17.1K 0.09% 142
2024
Q2
$208K Hold
268
0.16% 111
2024
Q1
$208K Buy
+268
New +$191K 0.16% 112

Other funds holding LLY

Holistic Planning's LLY Position: Q2 2026 in Review

Holistic Planning increased its Eli Lilly (LLY) stake by 70% in Q2 2026, buying an estimated $524K and bringing the position to 1,251 shares worth $1.5M. The position accounts for 0.23% of the portfolio, ranked #98.

Holistic Planning first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Holistic Planning held 1,251 shares of Eli Lilly worth $1.5M as of Q2 2026.
  • Holistic Planning bought 513 Eli Lilly shares in Q2 2026, an estimated $524K.
  • Eli Lilly made up 0.23% of Holistic Planning's portfolio in Q2 2026, its #98 holding.
  • Holistic Planning first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Holistic Planning's 13F filing for Q2 2026, filed 10 Aug 2026.